|
MLX expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.040200E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.062600E-03 |
| Normal-vs-Stage2 |
1.591220E-01 |
| Normal-vs-Stage3 |
1.150330E-04 |
| Normal-vs-Stage4 |
1.520020E-03 |
| Stage1-vs-Stage2 |
7.540400E-01 |
| Stage1-vs-Stage3 |
4.301900E-02 |
| Stage1-vs-Stage4 |
1.911570E-01 |
| Stage2-vs-Stage3 |
1.105400E-01 |
| Stage2-vs-Stage4 |
2.307600E-01 |
| Stage3-vs-Stage4 |
6.630600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.024280E-03 |
| Normal-vs-AfricanAmerican |
3.28949999994776E-06 |
| Normal-vs-Asian |
5.640400E-01 |
| Caucasian-vs-AfricanAmerican |
1.453750E-02 |
| Caucasian-vs-Asian |
2.542400E-01 |
| AfricanAmerican-vs-Asian |
1.086600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.444300E-04 |
| Normal-vs-Female |
1.331840E-02 |
| Male-vs-Female |
2.482000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.719300E-03 |
| Normal-vs-Age(41-60Yrs) |
2.104300E-03 |
| Normal-vs-Age(61-80Yrs) |
9.736200E-03 |
| Normal-vs-Age(81-100Yrs) |
2.291500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.658000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.018200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.105000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.095600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.554800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.775800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.820760E-01 |
| Normal-vs-Grade 2 |
2.357900E-02 |
| Normal-vs-Grade 3 |
3.620600E-04 |
| Normal-vs-Grade 4 |
7.025900E-04 |
| Grade 1-vs-Grade 2 |
8.902400E-01 |
| Grade 1-vs-Grade 3 |
6.638800E-01 |
| Grade 1-vs-Grade 4 |
4.594400E-01 |
| Grade 2-vs-Grade 3 |
1.092760E-01 |
| Grade 2-vs-Grade 4 |
6.995600E-02 |
| Grade 3-vs-Grade 4 |
4.976600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.950400E-01 |
| Normal-vs-ccB subtype |
1.58236999999728E-05 |
| ccA subtype-vs-ccB subtype |
3.01150000048267E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.755800E-03 |
| Normal-vs-N1 |
6.937600E-01 |
| N0-vs-N1 |
4.946000E-01 |
|
|
